Accenture to acquire French health consulting company OpusLine

Accenture to acquire French health consulting company OpusLine

Accenture has agreed to acquire OpusLine, a Paris-based health consulting company that offers strategic advisory and transformational services to public- and private-sector healthcare providers and also life sciences and insurance firms across France. The financial terms of the deal were not disclosed. The acquisition of OpusLine is expected to help Accenture’s position in catering to […]

CSS acquires regulatory reporting services provider AMFINE

CSS acquires regulatory reporting services provider AMFINE

RegTech company Compliance Solutions Strategies (CSS) has acquired AMFINE, a provider of SaaS-based regulatory reporting services to European asset managers, asset servicers, and insurers. The financial terms of the deal were not disclosed. Compliance Solutions Strategies provides technology-driven solutions for helping financial services companies to comply with mandatory regulatory compliance requirements. AMFINE, which has offices […]

Platinum Equity acquires sweet biscuits manufacturer Biscuit International

Platinum Equity acquires sweet biscuits manufacturer Biscuit International

Platinum Equity, a Los Angeles-based investment firm, has acquired Biscuit International, a European private label sweet biscuits manufacturer, from Qualium Investissement for an undisclosed price. Based in Paris, Biscuit International has a workforce of around 1,900 people. The sweet biscuits producer had registered sales of more than €500 million during the last 12 months, of […]

Cellectis begins MELANI-01 clinical trial for UCARTCS1 in multiple myeloma

Cellectis begins MELANI-01 clinical trial for UCARTCS1 in multiple myeloma

Cellectis said that it has dosed the first patient in a phase 1  study – the MELANI-01 clinical trial to evaluate UCARTCS1, an allogeneic off-the-shelf CAR-T product candidate for the treatment of relapsed/refractory multiple myeloma (R/R MM). The French gene therapy company began the phase 1 dose-escalation study after getting clearance from the US Food […]

Novartis aims to strengthen cell therapy capabilities with CellforCure acquisition

Novartis aims to strengthen cell therapy capabilities with CellforCure acquisition

Novartis has announced plans to acquire CellforCure, a French contract development and manufacturing organisation (CDMO), from LFB for an undisclosed amount. The deal underscores the Swiss pharmaceutical giant’s ambition to solidify its leadership in the cell and gene therapy market. Strategic acquisition of a key player The acquisition includes CellforCure’s manufacturing facility in Les Ulis […]

1 3 4 5